FT836mAbsolid tumorsprostatecervical cancers
…ograft models of prostate, ovarian, lung, and cervical cancers, FT836 achieved tumor growth inhibition rates of 94.5% ± 5.0% ( figure…
1articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: FT836 ×
FT836
This drug is selected. Its supporting articles are shown below.